OpenAlex
PricingAboutJobs
Log inGet started
Work

Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease

HTML

Year: 2017
Type: article
Source: Neurobiology of Aging
DOI: 10.1016/j.neurobiolaging.2017.08.028
Authors: Sofía Fernández-de Retana, Alex Montañola, Paula Marazuela, Maialen De La Cuesta, Aina Batlle, Marc Fatar, Saskia Grudzenski, Joan Montaner, Mar Hernández-Guillamon
Institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Heidelberg University
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: apolipoprotein A-I Milano, Alzheimer's disease, amyloid-beta, intravenous therapy, recombinant protein, amyloid fibril formation, endothelial protection, neuroinflammation, astrocytes, microglia, cerebral amyloid deposition, drug candidates
SDG: Good health and well-being

Open Access status: green

Funder: Instituto de Salud Carlos III
Award: Marcadores radiológicos y biológicos de disfunción cerebrovascular en la Angiopatía Amiloide Cerebral
OpenAlex ID: W2751275923
FWCI: 2.078
Cites: 61
Cited by: 53
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security